High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.5M
$2,534,566
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| FOLD |
AMICUS THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-02 | $322,839 | S | Form 4 |
| FOLD |
AMICUS THERAPEUTICS, INC.
|
CEO
Other
|
2026-01-20 | $457,500 | M | Form 4 |
| FOLD |
AMICUS THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-01-20 | $1,073,182Large | S | Form 4 |
| FOLD |
AMICUS THERAPEUTICS, INC.
|
CEO
Equity Compensation
|
2025-12-15 | $635,947x2 | M | Form 4 |
| FOLD |
AMICUS THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-12-15 | $846,011 | S | Form 4 |
| FOLD |
AMICUS THERAPEUTICS, INC.
|
CEO
Equity Compensation
|
2025-12-01 | $131,721x2 | M | Form 4 |
| FOLD |
AMICUS THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-12-01 | $146,011 | S | Form 4 |
| FOLD |
AMICUS THERAPEUTICS, INC.
|
CEO
Other
|
2025-11-24 | $131,721 | M | Form 4 |
| FOLD |
AMICUS THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-24 | $146,522 | S | Form 4 |